Reactive glycosylation endproducts in diabetic uraemia and treatment of renal failureZenji Makita, Jonathan Winston, Kirk R. Manogue et al.|The Lancet|1994Cited by 372
Inhibition of MIF Bioactivity by Rational Design of Pharmacological Inhibitors of MIF Tautomerase ActivityAngeles Dios, Yousef Al‐Abed, Robert A. Mitchell et al.|Journal of Medicinal Chemistry|2002Cited by 125